Abbott Laboratories (ABT) Q4 CY2024 Highlights: Revenue: $10.97 billion vs analyst estimates of $11.02 billion (7.2% year-on-year growth, in line) Adjusted EPS: $1.34 vs analyst estimates of $1.34 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback